Reynolds Capital Management’s Zimmer Biomet ZBH Stock Holding History

Reynolds Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,296	Closed	-$350K	–	202
2015 Q2	$350K	Hold	3,296	–	–	0.34%	110
2015 Q1	$376K	Buy	3,296 +412	+14%	+$47K	0.33%	105
2014 Q4	$318K	Buy	2,884 +103	+4%	+$10.9K	0.26%	153
2014 Q3	$271K	Buy	2,781 +206	+8%	+$20.3K	0.26%	145
2014 Q2	$260K	Sell	2,575 -1,648	-39%	-$161K	0.18%	244
2014 Q1	$388K	Buy	4,223 +618	+17%	+$57K	0.25%	146
2013 Q4	$326K	Buy	+3,605	New	+$312K	0.18%	219

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Reynolds Capital Management's ZBH Position: Q3 2015 in Review

Reynolds Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 3,296 shares — an estimated $350K sold.

Reynolds Capital Management first reported a position in ZBH in Q4 2013 and held it in 7 quarters. The position peaked at $388K in Q1 2014. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Reynolds Capital Management reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Reynolds Capital Management sold 3,296 Zimmer Biomet shares in Q3 2015, an estimated $350K.
Reynolds Capital Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 7 quarters.
Reynolds Capital Management's Zimmer Biomet position peaked at $388K in Q1 2014.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Reynolds Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.